LIQUIDIA TECHNOLOGIES
Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline:... LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types, and routes of administration.
LIQUIDIA TECHNOLOGIES
Industry:
Biopharma Biotechnology Nanotechnology Therapeutics
Founded:
2004-01-01
Address:
Morrisville, North Carolina, United States
Country:
United States
Website Url:
http://www.liquidia.com
Total Employee:
11+
Status:
Active
Contact:
(919)328-4400
Email Addresses:
[email protected]
Total Funding:
223.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
FibroGen
FibroGen, a research-based biotech firm, uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.
Raptor Pharmaceuticals
Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-06-29 | RareGen | RareGen acquired by Liquidia Technologies | N/A |
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Liquidia Technologies
Paul Manning
Paul Manning investment in Post-IPO Equity - Liquidia Technologies
Caligan Partners
Caligan Partners investment in Post-IPO Equity - Liquidia Technologies
Roger Jeffs
Roger Jeffs investment in Post-IPO Equity - Liquidia Technologies
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Liquidia Technologies
Eshelman Ventures
Eshelman Ventures investment in Post-IPO Equity - Liquidia Technologies
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Liquidia Technologies
AMDG 1
AMDG 1 investment in Post-IPO Equity - Liquidia Technologies
BKB Growth Investments
BKB Growth Investments investment in Post-IPO Equity - Liquidia Technologies
Canaan Partners
Canaan Partners investment in Post-IPO Equity - Liquidia Technologies
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-03 | Liquidia Corporation Announces Chief Executive Officer Transition |
| 2020-08-20 | Liquidia Announces Chief Financial Officer Transition |
| 2020-05-18 | Morrisville-based Liquidia names its first chief medical officer |
Official Site Inspections
http://www.liquidia.com Semrush global rank: 3.31 M Semrush visits lastest month: 4.88 K
- Host name: a23-212-248-135.deploy.static.akamaitechnologies.com
- IP address: 23.212.248.135
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
